4 Checks on Ondansetron for IBS Diarrhea

If a clinician suggests ondansetron for diarrhea-predominant irritable bowel syndrome, ask which symptom should improve and how the prescription will be reviewed.

Check the recruited population

TRITON randomized 80 adults with Rome IV IBS-D, including 47 women, against 400 planned. The 12-week UK trial closed early after slow recruitment and COVID-19 disruption. Doses were titrated to stool consistency, with adjustments during treatment. NIHR funded it.¹

Ask what supports your IBS diagnosis and which other causes of diarrhea have been assessed. Bring prior test results rather than relying on the name of a symptom alone.

Read the combined response definition

Response required both at least 30% less pain and at least 50% fewer days with loose stools for at least six of 12 weeks. 15/37 ondansetron recipients versus 12/43 placebo recipients responded; P = 0.19. The primary comparison was not statistically significant.¹

Write down whether pain, loose stools, urgency or leakage most limits your day. Ask how the review will capture that concern, including any effect on work or leaving home.

Separate stool consistency from combined benefit

Across weeks 1–12, adjusted mean Bristol stool scores favored ondansetron by 0.7 points (95% CI −1.0 to −0.3 for ondansetron minus placebo). This secondary finding does not establish combined pain-and-stool benefit.¹

Ask the prescriber to explain what a change on the stool scale would mean for your treatment goals. Keep a record of stool type and pain rather than summarizing the week as simply better or worse.

Review the off-label plan and safety checks

The 2021 BSG guideline lists ondansetron as a possible second-line option in specialist care, under a weak recommendation for its drug class. It predates TRITON and identifies constipation as the commonest side effect.²

US ondansetron labeling covers prevention of nausea and vomiting associated with chemotherapy, radiation or surgery; IBS treatment is off-label. Avoid use with congenital long-QT syndrome; apomorphine is contraindicated. The label recommends ECG monitoring with electrolyte abnormalities, heart failure, slow heart rhythms or other QT-prolonging medicines. It also warns about serotonin syndrome, particularly with serotonergic drugs.³

Have a pharmacist review all prescriptions and supplements, and discuss a plan for constipation. Agree who adjusts the dose, what should prompt contact and when continued use will be reassessed. The trial does not provide instructions for using leftover anti-nausea tablets yourself.

Bloated by Dinner includes “The Visit Script,” with prompts to describe your pattern, list medicines and supplements, and ask what has been ruled out and what comes next.